Search - tctmd.com

Displaying 1 - 13 of 13

Sort: Relevancy | Date

News Daily News

Stuart J. Connolly, Clinical Trialist and Arrhythmia Medicine Pioneer, Dies at 75

Shelley Wood

June 04, 2024

News Daily News

DOAC Don’ts: New Review Clarifies When Not to Use Direct Oral Anticoagulants

Shelley Wood

January 17, 2024

News Daily News

DOACs Safe, Effective in Subset of Valvular AF Patients

Shelley Wood

March 31, 2021

News Daily News

VITAL RHYTHM in Print: Dose Effects of Omega-3s on AF Still Unclear

Shelley Wood

March 17, 2021

News Daily News

Large US Study Links Air Pollution to Heart, Lung Diseases

Shelley Wood

February 26, 2021

News Daily News

New Meta-analysis Supports NOAC Plus P2Y12 Inhibitor for PCI in A-fib

Shelley Wood

February 28, 2020

News Daily News

FDA Advisors Decline to Recommend Vernakalant Approval

Shelley Wood

December 11, 2019

News Daily News

Switch Anticoagulants for A-fib Patients Needing a Stent? RE-DUAL PCI Insights

Shelley Wood

December 02, 2019

News Daily News

Continuing Anticoagulation During TAVR: New Data Offer a Glimpse of What Works

Shelley Wood

April 16, 2019

News Daily News

High Rates of Unnecessary Aspirin Use in A-fib/VTE Patients on Warfarin

Shelley Wood

March 08, 2019

News Daily News

Year in Review: Physicians Pick the Biggest News of 2017, in Interventional Cardiology and Beyond

Shelley Wood

December 26, 2017

News Daily News

Apixaban Recalled Following Complaints of Dose-Packaging Mismatch

Shelley Wood

June 13, 2017

News Daily News

New-Onset Atrial Fibrillation Post-CABG More Common, Lasts Longer in Men Than in Women

Shelley Wood

October 19, 2016

Advertisement

Stuart J. Connolly, Clinical Trialist and Arrhythmia Medicine Pioneer, Dies at 75

DOAC Don’ts: New Review Clarifies When Not to Use Direct Oral Anticoagulants

DOACs Safe, Effective in Subset of Valvular AF Patients

VITAL RHYTHM in Print: Dose Effects of Omega-3s on AF Still Unclear

Large US Study Links Air Pollution to Heart, Lung Diseases

New Meta-analysis Supports NOAC Plus P2Y12 Inhibitor for PCI in A-fib

FDA Advisors Decline to Recommend Vernakalant Approval

Switch Anticoagulants for A-fib Patients Needing a Stent? RE-DUAL PCI Insights

Continuing Anticoagulation During TAVR: New Data Offer a Glimpse of What Works

High Rates of Unnecessary Aspirin Use in A-fib/VTE Patients on Warfarin

Year in Review: Physicians Pick the Biggest News of 2017, in Interventional Cardiology and Beyond

Apixaban Recalled Following Complaints of Dose-Packaging Mismatch

New-Onset Atrial Fibrillation Post-CABG More Common, Lasts Longer in Men Than in Women

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content